Home > News > ACLARA Signs GlaxoSmithKline to eTag™ Access Agreement
July 30th, 2003
ACLARA Signs GlaxoSmithKline to eTag™ Access Agreement
Abstract:
ACLARA BioSciences announced today that it has entered into an eTag™ Access Agreement with GlaxoSmithKline (GSK), under which GSK will gain access to ACLARA's proprietary eTag Assay System for use in its biopharmaceutical research and development activities.
Source:
ACLARA
Related News Press |
Announcements
What heat can tell us about battery chemistry: using the Peltier effect to study lithium-ion cells March 8th, 2024
Nanoscale CL thermometry with lanthanide-doped heavy-metal oxide in TEM March 8th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||